Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000305292 | SCV000376708 | likely benign | Maturity onset diabetes mellitus in young | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000861723 | SCV001002115 | benign | not provided | 2023-12-31 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV000305292 | SCV002600906 | likely benign | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs201223431 with MODY3. | |
Prevention |
RCV003920271 | SCV004735445 | likely benign | HNF1A-related disorder | 2020-08-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004586676 | SCV005077590 | benign | not specified | 2024-04-18 | criteria provided, single submitter | clinical testing |